Literature DB >> 8875245

Down syndrome genetics: unravelling a multifactorial disorder.

D Hernandez1, E M Fisher.   

Abstract

Down syndrome is a common disorder affecting many tissues both during development and later on in adult life; the principle feature of all cases is a specific form of mental retardation, which is combined with a range of variable traits. Down syndrome is an aneuploidy syndrome that is caused by trisomy for human chromosome 21. While the phenotype is most likely due to a subtle increase in gene dosage of only a small minority of the estimated 500-800 genes that are present on this chromosome, the molecular genetics of Down syndrome remains speculative. However, recent advances on a number of fronts, including chromosome studies, gene identification and mouse modelling, are giving us the tools to dissect this multifactorial gene dosage disorder.

Entities:  

Mesh:

Year:  1996        PMID: 8875245     DOI: 10.1093/hmg/5.supplement_1.1411

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

1.  Replication asynchrony increases in women at risk for aneuploid offspring.

Authors:  A Amiel; O Reish; E Gaber; I Kedar; R Diukman; M Fejgin
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

2.  A contiguous 3-Mb sequence-ready map in the S3-MX region on 21q22.2 based on high- throughput nonisotopic library screenings.

Authors:  T Hildmann; X Kong; J O'Brien; L Riesselman; H M Christensen; E Dagand; H Lehrach; M L Yaspo
Journal:  Genome Res       Date:  1999-04       Impact factor: 9.043

3.  Scientific limitations and ethical ramifications of a non-representative Human Genome Project: African American response.

Authors:  Fatimah Jackson
Journal:  Sci Eng Ethics       Date:  1998-04       Impact factor: 3.525

4.  Chimpanzee Down syndrome: a case study of trisomy 22 in a captive chimpanzee.

Authors:  Satoshi Hirata; Hirohisa Hirai; Etsuko Nogami; Naruki Morimura; Toshifumi Udono
Journal:  Primates       Date:  2017-02-21       Impact factor: 2.163

5.  Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice.

Authors:  Eros Quarta; Gianluca Fulgenzi; Riccardo Bravi; Erez James Cohen; Sudhirkumar Yanpallewar; Lino Tessarollo; Diego Minciacchi
Journal:  Mol Cell Neurosci       Date:  2018-03-24       Impact factor: 4.314

6.  Genetic basis of cognitive disability.

Authors:  J Flint
Journal:  Dialogues Clin Neurosci       Date:  2001-03       Impact factor: 5.986

7.  Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus.

Authors:  Simone Granno; Jonathon Nixon-Abell; Daniel C Berwick; Justin Tosh; George Heaton; Sultan Almudimeegh; Zenisha Nagda; Jean-Christophe Rain; Manuela Zanda; Vincent Plagnol; Victor L J Tybulewicz; Karen Cleverley; Frances K Wiseman; Elizabeth M C Fisher; Kirsten Harvey
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

Review 8.  The importance of understanding individual differences in Down syndrome.

Authors:  Annette Karmiloff-Smith; Tamara Al-Janabi; Hana D'Souza; Jurgen Groet; Esha Massand; Kin Mok; Carla Startin; Elizabeth Fisher; John Hardy; Dean Nizetic; Victor Tybulewicz; Andre Strydom
Journal:  F1000Res       Date:  2016-03-23

9.  Rad51 and Rad54 promote noncrossover recombination between centromere repeats on the same chromatid to prevent isochromosome formation.

Authors:  Atsushi T Onaka; Naoko Toyofuku; Takahiro Inoue; Akiko K Okita; Minami Sagawa; Jie Su; Takeshi Shitanda; Rei Matsuyama; Faria Zafar; Tatsuro S Takahashi; Hisao Masukata; Takuro Nakagawa
Journal:  Nucleic Acids Res       Date:  2016-10-03       Impact factor: 16.971

Review 10.  Novel Approaches to an Integrated Route for Trisomy 21 Evaluation.

Authors:  Angelika Buczyńska; Iwona Sidorkiewicz; Anna Trochimiuk; Sławomir Ławicki; Adam Jacek Krętowski; Monika Zbucka-Krętowska
Journal:  Biomolecules       Date:  2021-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.